StonvexLoading…
StonvexStonvexStonvexCore line items from CSCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-07-26 | Annual 2024 2024-07-27 | Annual 2023 2023-07-29 | Annual 2022 2022-07-30 |
|---|---|---|---|---|
Revenue | $56.65B | $53.80B | $57.00B | $51.56B |
Operating Income | $11.76B | $12.18B | $15.03B | $13.97B |
Net Income | $10.18B | $10.32B | $12.61B | $11.81B |
EPS (Diluted) | $2.55 | $2.54 | $3.07 | $2.82 |
Total Assets | $122.29B | $124.41B | $101.85B | $94.00B |
Total Liabilities | $75.45B | $78.96B | $57.50B | $54.23B |
Cash & Equivalents | $8.35B | $7.51B | $10.12B | $7.08B |
Free Cash Flow OCF − CapEx | $13.29B | $10.21B | $19.04B | $12.75B |
Shares Outstanding | 3.96B | 4.01B | 4.07B | 4.11B |